Cookson Receives EU Approval for Acquisition of Foseco

Cookson Group plc, a leading materials science company, announces that it today obtained the necessary anti-trust clearance from the European Commission in connection with the proposed acquisition (the “Acquisition”) of Foseco plc. The European Commission clearance is subject to a remedy package that requires the disposal of Foseco’s Carbon Bonded Ceramics business (“CBC”) and of Cookson’s Hi- Tech Filters business (“Hi-Tech”). Hi-Tech is a supplier of ceramic foam filters. These disposals will be completed after the Acquisition becomes effective.

The intention to dispose of CBC was stated at the time of the announcement of the Acquisition on 11 October 2007. On 11 January 2008, Cookson announced that agreement had been reached to sell CBC to RHI AG, subject amongst other things to competition authority clearance and completion of the Acquisition.

For the year ended 31 December 2006, CBC had revenue of approximately £20 million and Hi-Tech approximately £9 million. As at 31 December 2006, the businesses had combined net assets of approximately £13 million.

The Acquisition is also subject to anti-trust clearance from the United States Department of Justice which is expected imminently. Cookson will make another announcement once such clearance is received.

As noted in Cookson’s Circular to its shareholders on 19 December 2007 and Foseco’s Circular to its shareholders on 22 February 2008, the current timetable has shareholder approval for the Acquisition being sought at Foseco’s EGM on 10 March and Cookson’s EGM on 11 March. The Acquisition is expected to become effective on 4 April 2008.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.